Xiangyu Jin

756 total citations
37 papers, 593 citations indexed

About

Xiangyu Jin is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Xiangyu Jin has authored 37 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Oncology and 8 papers in Immunology. Recurrent topics in Xiangyu Jin's work include Nanoparticle-Based Drug Delivery (4 papers), Lung Cancer Research Studies (4 papers) and Inflammasome and immune disorders (4 papers). Xiangyu Jin is often cited by papers focused on Nanoparticle-Based Drug Delivery (4 papers), Lung Cancer Research Studies (4 papers) and Inflammasome and immune disorders (4 papers). Xiangyu Jin collaborates with scholars based in China, United States and Poland. Xiangyu Jin's co-authors include Tengchuan Jin, Yajuan Li, Yuelong Li, Xiaocong Cao, Yi Huang, Didi Liu, Feng Guo, Fuqiang Hu, Rongbin Zhou and Yinchu Ma and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Xiangyu Jin

34 papers receiving 588 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangyu Jin China 13 238 187 91 69 64 37 593
Raj Kumar Verma India 16 258 1.1× 131 0.7× 76 0.8× 93 1.3× 40 0.6× 36 731
Tadahiro Nakamura Japan 18 466 2.0× 95 0.5× 148 1.6× 71 1.0× 66 1.0× 61 855
Su‐Yeon Kim South Korea 14 215 0.9× 122 0.7× 58 0.6× 79 1.1× 57 0.9× 63 660
Wenqing Ma China 14 173 0.7× 137 0.7× 69 0.8× 151 2.2× 41 0.6× 33 709
Lise Lefèvre France 14 303 1.3× 313 1.7× 83 0.9× 67 1.0× 38 0.6× 18 729
Bo Wei China 15 391 1.6× 207 1.1× 46 0.5× 67 1.0× 42 0.7× 43 808
Hélène Authier France 15 276 1.2× 281 1.5× 76 0.8× 52 0.8× 32 0.5× 23 659
Chuanbin Shen China 15 284 1.2× 162 0.9× 88 1.0× 65 0.9× 14 0.2× 37 809
Liliana Borges de Menezes Brazil 10 125 0.5× 86 0.5× 66 0.7× 28 0.4× 61 1.0× 39 585
Marc Daigneault United Kingdom 6 389 1.6× 515 2.8× 77 0.8× 82 1.2× 88 1.4× 7 1.1k

Countries citing papers authored by Xiangyu Jin

Since Specialization
Citations

This map shows the geographic impact of Xiangyu Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangyu Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangyu Jin more than expected).

Fields of papers citing papers by Xiangyu Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangyu Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangyu Jin. The network helps show where Xiangyu Jin may publish in the future.

Co-authorship network of co-authors of Xiangyu Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangyu Jin. A scholar is included among the top collaborators of Xiangyu Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangyu Jin. Xiangyu Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jin, Xiangyu, et al.. (2025). Drug Delivery Systems for Overcoming Physical Barriers in Cancer Therapy. Molecular Pharmaceutics. 22(11). 6413–6429. 1 indexed citations
3.
Zhou, Ying, Haiying Ding, Shujing Li, et al.. (2025). PreTA-mediated metabolism of 5-fluorouracil by intratumoral Citrobacter freundii drives chemoresistance in pancreatic cancer. Cell Reports. 44(11). 116473–116473.
4.
Zhou, Wentao, Yupeng Liu, Tingting Meng, et al.. (2024). NIR-Triggered Thermosensitive Nanoreactors for Dual-Guard Mechanism-Mediated Precise and Controllable Cancer Chemo-Phototherapy. Biomacromolecules. 25(2). 964–974. 4 indexed citations
5.
Jin, Xiangyu, et al.. (2024). Identification of a covalent NEK7 inhibitor to alleviate NLRP3 inflammasome-driven metainflammation. Cell Communication and Signaling. 22(1). 565–565. 1 indexed citations
6.
Wang, Kai, Wentao Zhou, Xiangyu Jin, et al.. (2024). The protective effects of Axitinib on blood-brain barrier dysfunction and ischemia-reperfusion injury in acute ischemic stroke. Experimental Neurology. 379. 114870–114870. 8 indexed citations
7.
Wang, Kai, Wentao Zhou, Xiangyu Jin, et al.. (2023). Enhanced brain delivery of hypoxia-sensitive liposomes by hydroxyurea for rescue therapy of hyperacute ischemic stroke. Nanoscale. 15(27). 11625–11646. 13 indexed citations
8.
Jin, Xiangyu, Yinchu Ma, Didi Liu, & Yi Huang. (2023). Role of pyroptosis in the pathogenesis and treatment of diseases. SHILAP Revista de lepidopterología. 4(3). e249–e249. 37 indexed citations
9.
Jin, Xiangyu, Rongbin Zhou, & Yi Huang. (2022). Role of inflammasomes in HIV-1 infection and treatment. Trends in Molecular Medicine. 28(5). 421–434. 21 indexed citations
10.
Tong, Yu, Xiangyu Jin, Fangying Yu, et al.. (2022). Tumor and dendritic cell dual-targeting nanocarriers maximize the therapeutic potential of IDO1 inhibitor in vivo. Nano Research. 15(10). 9204–9214. 2 indexed citations
11.
Jin, Xiangyu, et al.. (2021). Dynamic Stochastic Optimization of Emergent Blood Collection and Distribution from Supply Chain Perspective. Complexity. 2021(1). 2 indexed citations
12.
Yang, Xiqin, Yu Tong, Xueqing Zhou, et al.. (2020). Tumor-draining lymph node targeting chitosan micelles as antigen-capturing adjuvants for personalized immunotherapy. Carbohydrate Polymers. 240. 116270–116270. 25 indexed citations
13.
Wang, Jianwei, Shan Tao, Xiangyu Jin, et al.. (2020). Calcium Supplement by Tetracycline guided amorphous Calcium Carbonate potentiates Osteoblast promotion for Synergetic Osteoporosis Therapy. Theranostics. 10(19). 8591–8605. 34 indexed citations
14.
Li, Hui, et al.. (2019). Apatinib for chemotherapy-refractory extensive-stage SCLC: a retrospective study. Cancer Chemotherapy and Pharmacology. 83(6). 1083–1090. 13 indexed citations
15.
Jia, Wang, et al.. (2019). P2.14-38 ATAD2B-ALK, a Novel Fusion in Lung Adenocarcinoma Identified Using Next-Generation Sequencing (NGS). Journal of Thoracic Oncology. 14(10). S844–S844. 1 indexed citations
17.
Li, Yajuan, Yi Huang, Xiaocong Cao, et al.. (2018). Functional and structural characterization of zebrafish ASC. FEBS Journal. 285(14). 2691–2707. 28 indexed citations
18.
Hong, Wei, Hui Li, Xiangyu Jin, & Xun Shi. (2017). P1.07-053 Apatinib for Chemotherapy-Refractory Extensive Stage SCLC: Results from a Single-Center Retrospective Study. Journal of Thoracic Oncology. 12(1). S729–S729. 5 indexed citations
19.
Cao, Xiaocong, Yajuan Li, Xiangyu Jin, et al.. (2016). Molecular mechanism of divalent-metal-induced activation of NS3 helicase and insights into Zika virus inhibitor design. Nucleic Acids Research. 44(21). gkw941–gkw941. 32 indexed citations
20.
Feng, Tingting, Jinbo Cheng, Yajuan Li, et al.. (2016). Structure of the NS5 methyltransferase from Zika virus and implications in inhibitor design. Biochemical and Biophysical Research Communications. 492(4). 624–630. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026